Daniel Zheng

Daniel represents corporate clients and investment banks in a broad range of securities offerings, corporate finance transactions and general corporate matters.

Before joining Cooley, Daniel worked in the Hong Kong and Shanghai offices of two other top international law firms.

Daniel is a member of the New York State Bar Association. He is a native Mandarin speaker and fluent in English.

Daniel’s representative matters include:

US and Hong Kong initial public offerings (IPOs) and other capital markets transactions

• Meituan in its US$4.2 billion IPO and listing on the Hong Kong Stock Exchange (HKEX)
• New Oriental Education & Technology Group in its US$1.5 billion secondary listing on the HKEX
• KE Holdings in its $2.4 billion IPO and listing on the New York Stock Exchange (NYSE) and its $2.1 billion secondary offering of American depositary shares (ADSs)
• Li Auto in its US Securities and Exchange Commission (SEC)-registered at-the-market offering program for the sale of ADSs with an aggregate offering amount of up to $2 billion
• RLX Technology in its $1.2 billion IPO and listing on the NYSE
• NIO in its $1.1 billion IPO and listing on the NYSE
• Gaotu Techedu (formerly GSX Techedu) in its $208 million IPO and listing on the NYSE
• So-Young International in its $179 million IPO and listing on Nasdaq
• Citigroup, Morgan Stanley, Credit Suisse and other underwriters in the $100 million IPO of Youdao and its listing on the NYSE
• BlueCity Holdings Limited in its $85 million IPO and listing on Nasdaq
• Molecular Data in its $70 million IPO and listing on Nasdaq
• Niu Technologies in its $63 million IPO and listing on Nasdaq
• Deutsche Bank and China International Capital Corporation Limited in the $45 million SEC-registered follow-on offering of Class A ordinary shares of ECARX Holdings
• UCloudlink Group in its $36 million IPO and listing on Nasdaq

Equity financing

• KE Holdings in its $3.2 billion Series D and $1.5 billion Series D+ preferred share financings
• Dataa Robotics in its $58 million Series B preferred share financing